100 Glycan Microarray
100 glycan microarray service provided by CD BioGlyco helps researchers determine the binding partners for 100 diverse glycans in serum, proteins, plasma, cell cultures, cell/tissue lysates, or other potential biological samples, which represent the range of glycosylations found on cell membranes. We look forward to providing you with efficient scientific services in your research related to glycan microarray analysis.
Introduction
Glycocalyx is an extracellular polymer coating surrounding many eukaryotic and prokaryotic cells, consisting of glycolipids, glycoproteins, proteoglycans and glycosaminoglycans, which play important roles in cell signaling, viral infection and immune processes. Therefore, the clarification of glycan-associated biomolecular interactions and their consequences is critical for fundamental biology research and biomedical applications. However, there are currently very limited assay tools available for glycobiology research.
CD BioGlyco has worked to develop glycan microarrays for the rapid analysis of glycan-related recognition events. Because they contain numerous glycans immobilized in a compact and ordered manner on a solid surface, glycan microarrays allow for multiple parallel analyses of glycan-protein interaction using only a small number of glycan samples. Microarray technology is now being used as an effective tool to elucidate the role of glycans and glycan-binding proteins in biological systems.
Fig.1 Glycoconjugates on mammalian cell membranes. (Li, et al., 2021)
Our Services
CD BioGlyco provides customers with microarray analysis of 100 synthetic glycans. The most common identified structures displaying important binding functions in the literature are included, such as β-Glc-sp, β-Gal-sp, α-Man-sp, β-GlcNAc-sp, Neu5Ac-α-2,3-Gal-β-1,3-GlcNAc-β-sp, Gal-α-1,4-Gal-β-1,4-Glc-β-sp, GlcNAc-β-1,6-GlcNAc-β-sp, Neu5Gc-α-2,3-Gal-β-1,3-(Fuc-α-1,4)-GlcNAc-β-sp [Sialyl Lewis A], GlcNAc-β-1,6-(Gal-β-1,3)-GalNAc-α-O-Ser, GlcNAc-β-1,4-GlcNAc-β-sp, Gal-β-1,3-GalNAc-β-sp, Gal-α-1,3-(Fuc-α-1,2)-Gal-β-1,4-Glc-β-sp [Blood B antigen tetrasaccharide], GalNAc-β-1,4-(Neu5Ac-α-2,8-Neu5Ac-α-2,3)-Gal-β-1,4-Glc-β-sp [GD2], Neu5Ac-α-2,8-Neu5Ac-α-2,6-Gal-β-1,4-Glc-sp, etc. For more information about glycans, please contact us directly.
We provide 100 glycan microarray services to help researchers:
- Determination of glycans binding partners in various biological samples
- Rapid profiling of glycan-binding properties of proteins
- Evaluation of substrate specificities of several glycosyltransferases
- Screening for glycans that promote cell surface lectin-related cellular responses
- Study on inflammatory immune responses
Workflow
- 100 glycan microarray construction: We prepare various glycans through chemical synthesis or enzymatic synthesis. We then select a suitable functionalized glass slide surface and couple the synthesized glycans with linkers compatible with the printing surface, and print the glycan conjugates onto the glass slides.
- Sample preparation and labeling: We carefully process various samples according to established protocols and label them with fluorescent tags or other detectable labels.
- Microarray incubation and washing: Under precisely controlled conditions, the labeled target molecules are carefully incubated with the 100 glycan microarray. Non-specific binding materials are removed through washing. The microarray is scanned, and the bound materials are measured using a microarray scanner. The generated images can then be analyzed using various methods to produce microarray results. Our advanced equipment ensures accurate and sensitive detection of binding interactions.
- Data analysis: We use advanced software and algorithms to process raw data, provide detailed interpretations, and generate comprehensive reports. We also address any questions that may arise afterward.

Advantages
- The microarray format is designed to simultaneously analyze the interactions between the target molecule and 100 different glycans. This significantly accelerates the research process compared to traditional methods, which analyze one glycan at a time.
- Our glycan microarrays include a wide range of common and biologically relevant glycan structures, helping researchers gain a comprehensive understanding of the binding specificity of the target molecule.
- Glycan microarray assays are performed under controlled conditions with highly reproducible and reliable results.
Applications
- The 100 glycan microarray is used to discover and screen novel glycan-binding proteins in various biological samples and to determine their glycan-binding specificity.
- The 100 glycan microarray is used to understand glycan-protein interactions to analyze various biological processes, disease mechanisms, potential therapeutic targets, and more.
- The 100 glycan microarray is used to screen drug candidates for interactions with specific glycans.
Publication Data
Technology: Glycan microarray
Journal: Beilstein Journal of Organic Chemistry
IF: 2.622
Published: 2020
Results: This article provides a detailed overview of the general workflow for glycan microarray analysis and the tools available for analyzing microarray data. Several types of functionalized slide surfaces are available for selection, such as nitrocellulose, epoxy resin, N-hydroxysuccinimide (NHS), polyvinylidene fluoride (PVDF), etc., which can be used to construct glycan microarrays. The choice of surface typically depends on the type of glycan conjugates to be printed, as well as the glycan binding proteins (GBPs) and detection wavelength used. There are numerous glycan microarray chip data repositories available, including the Consortium for Functional Glycomics (CFG) database, CarbArrayART, and the GlyGen microarray repository. Tools such as GLycan Array Dashboard (GLAD) and Glycan Microarray Database (GlyMDB) can be used for data visualization and combined analysis.
Fig.2 Visualization workflow for free oligosaccharide array data (Mehta, et al., 2020)
Frequently Asked Questions
Equipped with high throughput and automated facilities, CD BioGlyco has developed glycans array analysis platform for screening protein-carbohydrate interactions. Our high-efficient systems help customers reduce project costs and timelines to accelerate their research. If you need our scientific services, please contact us for further consultation.
Associated Services

- GPI Anchor Pathway-based Glyco-engineered Cell Construction Service
- Glycolipids (GSL) Pathway-based Glyco-engineered Cell Construction Service
- N-linked Glycan Pathway-based Glyco-engineered Cell Construction Service
- O-GalNAc Pathway-based Glyco-engineered Cell Construction Service
- O-Fuc Pathway-based Glyco-engineered Cell Construction Service
- O-Man Pathway-based Glyco-engineered Cell Construction Service
- C-Man Pathway-based Glyco-engineered Cell Construction Service
- O-Glc Pathway-based Glyco-engineered Cell Construction Service
References
- Mehta, A.Y.; et al. Tools for generating and analyzing glycan microarray data. Beilstein Journal of Organic Chemistry. 2020, 16(1): 2260-2271. (Open Access)
- Li, Y.; et al. The importance of glycans of viral and host proteins in enveloped virus infection. Frontiers in Immunology. 2021, 12: 638573. (Open Access)
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform







